Sebelipase Alfa Strength Indicated Is For Final Drug Product And Is Not Administered To The Animal
11 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
11
Total Reports
11
Deaths Reported
10000.0%
Death Rate
Active Ingredients
Sebelipase Alfa Strength Indicated Is For Final Drug Product And Is Not Administered To The Animal
Administration Routes
Unknown
Species Affected
Chicken 11
Most Affected Breeds
Unknown 11
Most Reported Reactions
IGA Animal mortality greater than expected 11
IGA Animal morbidity greater than expected 9
Found dead 3
Death 2
Death by euthanasia 2
Fracture 2
Unrelated death 1
Outcome Breakdown
Died
9 (50.0%)
Euthanized
9 (50.0%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.